Mkt Cap (₹ Cr.)
Face Value (₹)
- Regulation 23(9)-Disclosure Of Related Party Transactions On Consolidated Basis For The Year Ended On 31St March, 2020
- Declaration Under Regulation 33 (3) (D) Of The SEBI (LODR) Regulations, 2015.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Shareholding for the Period Ended June 30, 2020
- Closure of Trading Window
- Format of Initial Disclosure to be made by an entity identified as a Large Corporate
- Disclosure Of Material Impact Of COVID-19 Pandemic On The Company.
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Audited Consolidated And Standalone Financial Results For The 4Th Quarter And Year Ended 31St March, 2020.
- Outcome Of The Board Meeting-30.06.2020
Vivo Bio Tech Ltd. Earnings(Figures in Rs. Cr.)
Vivo Bio Tech Ltd. Stock Performance
Vivo Bio Tech Ltd. Financial Performance
Vivo Bio Tech Ltd. Financial Comparison with peers
About Vivo Bio Tech Ltd.
Vivo Bio Tech Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 37.31 Crore) operating in Miscellaneous sector.
Vivo Bio Tech Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 28.58 Crore to Sales Value (100.00 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-03-2020, the company has reported a Consolidated sales of Rs 14.36 Crore, up 1.76 % from last quarter Sales of Rs 14.11 Crore and up 4.29 % from last year same quarter Sales of Rs 13.76 Crore Company has reported net profit after tax of Rs -.41 Crore in latest quarter.
The company’s top management includes Dr.Alangudi Sankaranarayanan, Mr.M Kalyan Ram, Mr.R Hariharan, Mr.Sunder Kanaparthy, Mr.Tejomurthula Viswaswara Kaladhar Kuppambhotla, Mrs.M Vijaya Lakshmi. Company has PCN & Associates as its auditors As on 30-06-2020, the company has a total of 12,887,520 shares outstanding.